argenx SE (ARGX)
1023.21
-35.69
(-3.37%)
USD |
NASDAQ |
Aug 28, 16:00
1023.05
-0.16
(-0.02%)
After-Hours: 20:00
argenx Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2014 | 0.3308M |
| Date | Value |
|---|---|
| March 31, 2014 | -3.157M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Autolus Therapeutics Plc | -25.16M |
| Akari Therapeutics Plc | -3.112M |
| Forte Biosciences, Inc. | -22.70M |
| Evaxion AS | -- |
| DBV Technologies SA | -52.52M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | 1.090B |
| Free Cash Flow Yield | 1.63% |